1. Home
  2. SNY vs ELV Comparison

SNY vs ELV Comparison

Compare SNY & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$45.02

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Logo Elevance Health Inc.

ELV

Elevance Health Inc.

HOLD

Current Price

$415.53

Market Cap

85.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNY
ELV
Founded
1994
1944
Country
France
United States
Employees
74846
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.5B
85.7B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
SNY
ELV
Price
$45.02
$415.53
Analyst Decision
Buy
Buy
Analyst Count
5
19
Target Price
$58.00
$383.56
AVG Volume (30 Days)
2.4M
1.4M
Earning Date
04-23-2026
04-22-2026
Dividend Yield
3.47%
1.83%
EPS Growth
N/A
N/A
EPS
N/A
8.00
Revenue
N/A
$199,125,000,000.00
Revenue This Year
$3.49
N/A
Revenue Next Year
$6.10
$3.07
P/E Ratio
$6.14
$51.17
Revenue Growth
N/A
12.49
52 Week Low
$42.28
$273.71
52 Week High
$52.68
$411.80

Technical Indicators

Market Signals
Indicator
SNY
ELV
Relative Strength Index (RSI) 55.05 68.74
Support Level $43.32 $307.16
Resistance Level $45.12 N/A
Average True Range (ATR) 0.55 9.81
MACD 0.16 -0.87
Stochastic Oscillator 89.70 92.56

Price Performance

Historical Comparison
SNY
ELV

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About ELV Elevance Health Inc.

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Share on Social Networks: